NIH-funded research R21 grant

Using artificial intelligence to improve evaluation of Meibomian glands in dry eye patients

Official title: A Second Look at DREAM: Towards a New Paradigm in Meibomian Gland Evaluation Using Artificial Intelligence

Funded at University of California Berkeley · NIH-10703363 · Data updated 2026-11-12

This study is looking at how we can use advanced technology to better understand and treat dry eye disease caused by problems with the glands in your eyelids, so that you can get more accurate diagnoses and personalized treatments.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California Berkeley
NIH-funded
Lab location1 site (Berkeley, United States)
Project startSeptember 30, 2022
Project endAugust 31, 2025
Funding year2023
Award (this year)$178,372
NIH project number5R21EY033881-02
Project IDNIH-10703363 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals experiencing symptoms of dry eye disease, particularly those with suspected Meibomian gland dysfunction.

Less likely to help

Patients who do not have symptoms of dry eye or Meibomian gland dysfunction may not benefit from this research.

What this research studies

This research focuses on improving the diagnosis and treatment of dry eye disease, which is often caused by Meibomian gland dysfunction. By utilizing advanced artificial intelligence techniques, the study aims to analyze meibography images—infrared images of the eyelids that show the Meibomian glands—to better understand their characteristics and how they relate to dry eye symptoms. The goal is to create a more accurate and efficient method for evaluating these glands, which could lead to improved patient outcomes. Patients may benefit from more precise diagnoses and tailored treatments based on AI-driven insights.

Why it matters

Potential benefit: If successful, this research could lead to more accurate diagnoses and effective treatments for patients suffering from dry eye disease.

How similar studies have gone: Other research has shown promise in using artificial intelligence for medical imaging analysis, suggesting that this approach could yield significant advancements in understanding Meibomian gland dysfunction.

Where this research is happening

  • University of California Berkeley
    Berkeley, United States
    Active

Researchers

  • Principal investigator: Lin, Meng Ching — University of California Berkeley
  • Study coordinator: Lin, Meng Ching

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.